UY24425A1 - Derivados de tiol con actividad inhibidora de metalopeptidasa. - Google Patents
Derivados de tiol con actividad inhibidora de metalopeptidasa.Info
- Publication number
- UY24425A1 UY24425A1 UY24425A UY24425A UY24425A1 UY 24425 A1 UY24425 A1 UY 24425A1 UY 24425 A UY24425 A UY 24425A UY 24425 A UY24425 A UY 24425A UY 24425 A1 UY24425 A1 UY 24425A1
- Authority
- UY
- Uruguay
- Prior art keywords
- metalopeptidase
- inhibitor activity
- thiol derivatives
- heteroatoms
- possibilities
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Treatment Of Fiber Materials (AREA)
- Preliminary Treatment Of Fibers (AREA)
Abstract
Se describe un compuesto de fórmula (I) (figura 1) donde R es un grupo mercapto o un grupo R4COS convertible en el organismo en un grupo mercapto: R1 es, entre otras posibilidades, un heterociclo aromático de 5 o 6 miembros con uno o dos heteroátomos; R3 es, entre otras posibilidades, un heterocíclo aromático de 5 o 6 miembros con uno o dos heteroátomos; y sales farmaceuticamente aceptables de los mismos. Como ejemplo no limitante: metil éster de N-(3-fenilcarnoniltio-2-fenilmetilpropionil)4-(2-tiazolil)-L-fenilalanina. Los compuestos son útiles en en tratamiento de enfermedades cardiovasculares.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95MI002773A IT1277737B1 (it) | 1995-12-28 | 1995-12-28 | Derivati tiolici ad attivita' inibitrice delle metallopeptidasi |
Publications (1)
Publication Number | Publication Date |
---|---|
UY24425A1 true UY24425A1 (es) | 1997-01-09 |
Family
ID=11372827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY24425A UY24425A1 (es) | 1995-12-28 | 1996-12-27 | Derivados de tiol con actividad inhibidora de metalopeptidasa. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0877740B1 (es) |
JP (1) | JP2000502687A (es) |
KR (1) | KR19990076809A (es) |
CN (1) | CN1071325C (es) |
AP (1) | AP1186A (es) |
AR (1) | AR004413A1 (es) |
AT (1) | ATE292123T1 (es) |
AU (1) | AU713156B2 (es) |
BG (1) | BG63942B1 (es) |
BR (1) | BR9612373A (es) |
CA (1) | CA2241414A1 (es) |
CZ (1) | CZ204698A3 (es) |
DE (1) | DE69634543D1 (es) |
EA (1) | EA000991B1 (es) |
EE (1) | EE03766B1 (es) |
GE (1) | GEP19991871B (es) |
HK (1) | HK1018008A1 (es) |
IL (1) | IL124915A (es) |
IS (1) | IS1885B (es) |
IT (1) | IT1277737B1 (es) |
NO (1) | NO310914B1 (es) |
NZ (1) | NZ325785A (es) |
OA (1) | OA10704A (es) |
PL (1) | PL188151B1 (es) |
RO (1) | RO119882B1 (es) |
SK (1) | SK282977B6 (es) |
TR (1) | TR199801229T2 (es) |
UA (1) | UA62923C2 (es) |
UY (1) | UY24425A1 (es) |
WO (1) | WO1997024342A1 (es) |
ZA (1) | ZA9610891B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1289522B1 (it) * | 1996-12-24 | 1998-10-15 | Zambon Spa | Processo per la preparazione di eteroaril-fenilalanine |
MY153569A (en) | 1998-01-20 | 2015-02-27 | Mitsubishi Tanabe Pharma Corp | Inhibitors of ?4 mediated cell adhesion |
US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
GB0203665D0 (en) * | 2002-02-15 | 2002-04-03 | Glaxo Group Ltd | Process |
MY140707A (en) | 2002-02-28 | 2010-01-15 | Mitsubishi Tanabe Pharma Corp | Process for preparing a phenylalanine derivative and intermediates thereof |
DE60336986D1 (de) | 2002-03-05 | 2011-06-16 | Sumitomo Chemical Co | Verfahren zur herstellung von biarylverbindungen |
TW200407310A (en) * | 2002-06-07 | 2004-05-16 | Glaxo Group Ltd | Compounds |
GB0213122D0 (en) * | 2002-06-07 | 2002-07-17 | Glaxo Group Ltd | Compounds |
US7045653B2 (en) | 2002-12-23 | 2006-05-16 | Pfizer, Inc. | Pharmaceuticals |
GB0327839D0 (en) | 2003-12-01 | 2003-12-31 | Novartis Ag | Organic compounds |
KR20070006774A (ko) | 2004-03-17 | 2007-01-11 | 노파르티스 아게 | 치료에서 레닌 억제제의 용도 |
CA2757650C (en) | 2009-04-03 | 2016-06-07 | Statoil Asa | Equipment and method for reinforcing a borehole of a well while drilling |
US9199914B2 (en) | 2010-02-03 | 2015-12-01 | Meh Associates, Inc. | Multiple substituted fluoromethanes as selective and bioactive isosteres |
AR080683A1 (es) | 2010-03-16 | 2012-05-02 | Novartis Ag | Composiciones farmaceuticas de aliskiren y metodos de administracion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401677A (en) * | 1981-10-09 | 1983-08-30 | E. R. Squibb & Sons, Inc. | Enkephalinase inhibitors |
FR2652087B1 (fr) * | 1989-09-15 | 1993-10-15 | Bioprojet Ste Civile | Derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques. |
FR2682952B1 (fr) * | 1991-10-25 | 1993-12-03 | Institut Nal Sante Recherc Medic | Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent. |
IT1273455B (it) * | 1995-01-27 | 1997-07-08 | Zambon Spa | Derivati tiolici ad attivita' inibitrice delle metallopeptidasi |
-
1995
- 1995-12-28 IT IT95MI002773A patent/IT1277737B1/it active IP Right Grant
-
1996
- 1996-12-17 BR BR9612373A patent/BR9612373A/pt not_active Application Discontinuation
- 1996-12-17 GE GEAP19964406A patent/GEP19991871B/en unknown
- 1996-12-17 TR TR1998/01229T patent/TR199801229T2/xx unknown
- 1996-12-17 CA CA002241414A patent/CA2241414A1/en not_active Abandoned
- 1996-12-17 EA EA199800544A patent/EA000991B1/ru not_active IP Right Cessation
- 1996-12-17 EE EE9800192A patent/EE03766B1/xx not_active IP Right Cessation
- 1996-12-17 SK SK889-98A patent/SK282977B6/sk unknown
- 1996-12-17 DE DE69634543T patent/DE69634543D1/de not_active Expired - Lifetime
- 1996-12-17 EP EP96944583A patent/EP0877740B1/en not_active Expired - Lifetime
- 1996-12-17 KR KR1019980704934A patent/KR19990076809A/ko not_active Application Discontinuation
- 1996-12-17 CN CN96199354A patent/CN1071325C/zh not_active Expired - Fee Related
- 1996-12-17 RO RO98-01109A patent/RO119882B1/ro unknown
- 1996-12-17 CZ CZ982046A patent/CZ204698A3/cs unknown
- 1996-12-17 AU AU13018/97A patent/AU713156B2/en not_active Ceased
- 1996-12-17 NZ NZ325785A patent/NZ325785A/en unknown
- 1996-12-17 JP JP09524001A patent/JP2000502687A/ja not_active Ceased
- 1996-12-17 PL PL96327580A patent/PL188151B1/pl not_active IP Right Cessation
- 1996-12-17 AT AT96944583T patent/ATE292123T1/de not_active IP Right Cessation
- 1996-12-17 WO PCT/EP1996/005663 patent/WO1997024342A1/en not_active Application Discontinuation
- 1996-12-17 UA UA98074090A patent/UA62923C2/uk unknown
- 1996-12-17 AP APAP/P/1998/001264A patent/AP1186A/en active
- 1996-12-17 IL IL12491596A patent/IL124915A/en not_active IP Right Cessation
- 1996-12-23 ZA ZA9610891A patent/ZA9610891B/xx unknown
- 1996-12-27 AR ARP960105957A patent/AR004413A1/es not_active Application Discontinuation
- 1996-12-27 UY UY24425A patent/UY24425A1/es not_active IP Right Cessation
-
1998
- 1998-06-18 BG BG102553A patent/BG63942B1/bg unknown
- 1998-06-22 IS IS4780A patent/IS1885B/is unknown
- 1998-06-26 NO NO19982977A patent/NO310914B1/no unknown
- 1998-06-26 OA OA9800094A patent/OA10704A/en unknown
-
1999
- 1999-07-20 HK HK99103110A patent/HK1018008A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY24425A1 (es) | Derivados de tiol con actividad inhibidora de metalopeptidasa. | |
AU6309694A (en) | Piperazine derivatives | |
DK0513387T3 (da) | Thiazolderivater som inhibitorer af aktivt oxygen | |
PE20010482A1 (es) | Derivados de 3-ureido-pirazol y procedimiento para su preparacion | |
DE3867572D1 (de) | Benzothiazol-derivat und es als aktiven bestandteil enthaltendes antirheumatisches mittel. | |
DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
MX9709475A (es) | Derivados de pirrol y composicion medicinal. | |
SE8504014L (sv) | Etylendiaminmonoamid-derivat | |
NZ515197A (en) | Hydroxamic acid derivatives useful as matrix metalloprotease inhibitors | |
UY25211A1 (es) | Inhibidores de isoquinolinilguanidina uroquinasa | |
KR880007457A (ko) | 프롤리날 유도체 | |
ES2038754T3 (es) | Agentes antiarritmicos. | |
ES2032437T3 (es) | Inmunoestimulantes heptanoil-glu-asp-ala-aminoacidos. | |
DE69522118D1 (de) | Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält | |
DE68906965D1 (de) | Analgetische phenothiazinderivate. | |
ATE219775T1 (de) | Indolverbindungen, ihre verwendung zum färben und schminken von keratinfasern, sie enthaltende zusammensetzungen und färbeverfanren | |
ATE50257T1 (de) | Kristalline form von benzothiazindioxydsalz. | |
ATE75399T1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
MX9305918A (es) | Derivados de n-(2-amino-2-oxoetil)butanodiamida inhibidores de la renina procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
NO893039D0 (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. | |
ES2195600T3 (es) | Procedimiento mejorado para la preparacion de derivados de tiazolidina-2,4-diona. | |
FR2426685A2 (fr) | Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension | |
ECSP961892A (es) | Procedimientos para inhibir el inhibidor del activador del plasminogeno 1 | |
NO912420L (no) | Antiatherosklerotiske og antitrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoksazin-4-oner. | |
RU95120104A (ru) | Производное серина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VENC | Patent expired |
Effective date: 20161227 |